rs911762606
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_031372.4(HNRNPDL):āc.110A>Cā(p.Gln37Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,383,816 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_031372.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNRNPDL | NM_031372.4 | c.110A>C | p.Gln37Pro | missense_variant | 1/8 | ENST00000295470.10 | NP_112740.1 | |
HNRNPDL | NM_001207000.1 | c.110A>C | p.Gln37Pro | missense_variant | 1/7 | NP_001193929.1 | ||
HNRNPDL | NR_003249.2 | n.645A>C | non_coding_transcript_exon_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNRNPDL | ENST00000295470.10 | c.110A>C | p.Gln37Pro | missense_variant | 1/8 | 1 | NM_031372.4 | ENSP00000295470.5 |
Frequencies
GnomAD3 genomes AF: 0.000617 AC: 93AN: 150670Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000306 AC: 5AN: 16354Hom.: 0 AF XY: 0.000480 AC XY: 4AN XY: 8336
GnomAD4 exome AF: 0.00108 AC: 1336AN: 1233046Hom.: 1 Cov.: 32 AF XY: 0.00104 AC XY: 625AN XY: 598706
GnomAD4 genome AF: 0.000617 AC: 93AN: 150770Hom.: 0 Cov.: 32 AF XY: 0.000421 AC XY: 31AN XY: 73648
ClinVar
Submissions by phenotype
Autosomal dominant limb-girdle muscular dystrophy type 1G Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 13, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2021 | The c.110A>C (p.Q37P) alteration is located in exon 1 (coding exon 1) of the HNRNPDL gene. This alteration results from a A to C substitution at nucleotide position 110, causing the glutamine (Q) at amino acid position 37 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at